Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a tiny ear device ease severe PMS and menopause symptoms?

NCT ID NCT07688720

Recruiting now Symptom relief Sponsor: Texas Christian University Source: ClinicalTrials.gov ↗

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study tests whether a small, wearable device that gently stimulates nerves in the ear can improve mood and physical symptoms in women with premenstrual dysphoric disorder (PMDD) or perimenopause. Participants use the device daily and report their symptoms through online surveys. The goal is to see if this non-invasive approach offers relief without medication.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
transcutaneous auricular neurostimulation (tAN) device (Sparrow Link)
What this could lead to
If it works, this could offer a drug-free, at-home option for managing PMDD and perimenopause symptoms.
What could go wrong
This is a very small early study (20 people) with no control group, so results may not be conclusive or generalizable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIMENOPAUSE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

premenstrual dysphoric disorder premenstrual tension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PERIMENOPAUSE PMDD

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Texas Christian University

    RECRUITING

    Fort Worth, Texas, 76109, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.